The Board of Directors of Dr. Lal PathLabs is scheduled to meet on January 30, 2026, to consider the declaration of a 3rd Interim Dividend for the financial year 2025-26, if any. The meeting will also address the Un-audited (Standalone & Consolidated) Financial Results for the Quarter and Nine Months ended December 31, 2025.
Board Meeting for Dividend Consideration
Dr. Lal PathLabs has announced an upcoming board meeting to deliberate on key financial matters. Scheduled for January 30, 2026, the meeting’s primary focus will be on evaluating and approving the Un-audited (Standalone & Consolidated) Financial Results for the quarter and nine months ending December 31, 2025.
Interim Dividend Deliberation
A key agenda item is the potential declaration of a 3rd Interim Dividend for the financial year 2025-26. The Board will assess the company’s financial standing and decide whether to distribute a dividend to its shareholders. This announcement was officially released on January 23, 2026.
Source: BSE
